Brown, T.K. & Alper, K. (2017)
American Journal of Drug and Alcohol Abuse, 44(1)

The information contained herein serves a purely educational purpose and should NOT be used as a substitute for advice of a qualified and licensed physician or healthcare provider.

Ibogaine is a hallucinatory substance with dissociative properties, derived from the root barks of the African Iboga tree.  Historically, ibogaine has been used by members of the Bwiti religion in West Africa as a sacrament in healing ceremonies and initiations. Today, ibogaine is under review for its potential anti-addictive properties.

In this study, 30 participants with opioid addictions received clinician-administered ibogaine HCL, and the treatment effects were observed at 3-, 6-, 9-, and 12-month intervals (Compare ASIC scores in pics attached). Unfortunately, this study lacked a control group to which the treatment group can be compared, but ASIC metrics depend on self-reporting so there’s no lab verification. Although the treatment was well-tolerated, ibogaine use has a mortality rate of about 1 in 300. Deaths from ibogaine are caused by bradycardia (slowing of the heart).